Russell A Judge
8PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 04, 2024
BCL-XL-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors.Andrew S Judd, Bhupinder Bawa, Wayne R Buck
|Mar 22, 2024
Minimising the payload solvent exposed hydrophobic surface area optimises the antibody-drug conjugate properties.Adrian D Hobson, Haizhong Zhu, Wei Qiu
|Mar 20, 2024
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma.Joshua P Plotnik, Adam E Richardson, Haopeng Yang
|Oct 29, 2023
Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognition.Janani Sridar, Amirhossein Mafi, Russell A Judge
|Oct 25, 2023
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients.Junichiro Yuda, Christine Will, Darren C Phillips
|Sep 28, 2022
Author Correction: Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition.Russell A Judge, Janani Sridar, Kathryn Tunyasuvunakool
Pageof 2
Frequent Collaborators
3 joint publications
Dan Eaton
3 joint publications
Qi Hao
2 joint publications
Andrew J Souers
2 joint publications
Kathryn Tunyasuvunakool
2 joint publications
John Jumper
2 joint publications
Jin Wang
2 joint publications
Ruth L Martin
2 joint publications
Wayne R Buck
1 joint publications
Andrew Phillips
1 joint publications
Jie Chen
